\-\ Texto\\:\\ \ \(0\)\
\-\ thin\\ older\\ man\\.\ \(0\)\
\-\ bone\\ scan\\ \\(t99m\\-mdp\\)\\:\\ mutlifocal\\ nodular\\ areas\\ of\\ increased\\ uptake\\ throughout\\ the\\ skeleton\\.\ \(0\)\
\-\ quadramet\\ \\(samarium\\-153\\)\\:\\ given\\ to\\ treat\\ bone\\ pain\\.\\ the\\ images\\ were\\ acquired\\ approximately\\ 10\\ minutes\\ after\\ injection\\ of\\ the\\ radiotracer\\.\\ \\ although\\ quadramet\\ is\\ rarely\\ used\\ as\\ a\\ diagnostic\\ agent\\,\\ it\\ does\\ give\\ off\\ gamma\\ radiation\\ that\\ can\\ be\\ imaged\\.\\ in\\ this\\ case\\,\\ the\\ findings\\ are\\ very\\ similar\\ to\\ those\\ seen\\ on\\ the\\ bone\\ scan\\.\ \(0\)\
\-\ bone\\ metastasis\\,\\ secondary\\ to\\ prostate\\ cancer\\.\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ sclerotic\\ multiple\\ myleoma\ \(0\)\
\-\ extreme\\ diffuse\\ bone\\ pain\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ quadramet\\:\\ 0\\.40069439820279984\ \(0\)\
\-\ bone\\:\\ 0\\.34177859651781173\ \(0\)\
\-\ mutlifocal\\:\\ 0\\.20034719910139992\ \(0\)\
\-\ myleoma\\:\\ 0\\.19144244450404416\ \(0\)\
\-\ give\\:\\ 0\\.14870670226794752\ \(0\)\
\-\ scan\\:\\ 0\\.14865239283942883\ \(0\)\
\-\ extreme\\:\\ 0\\.14238867833440982\ \(0\)\
\-\ agent\\:\\ 0\\.1401533444007044\ \(0\)\
\-\ skeleton\\:\\ 0\\.13626762278030624\ \(0\)\
\-\ gamma\\:\\ 0\\.1351114702078604\ \(0\)\
\-\ imaged\\:\\ 0\\.13455544488648322\ \(0\)\
\-\ treat\\:\\ 0\\.1267771847516034\ \(0\)\
\-\ the\\:\\ 0\\.12498775407309447\ \(0\)\
\-\ prostate\\:\\ 0\\.12134364922737746\ \(0\)\
\-\ acquired\\:\\ 0\\.12075005019778466\ \(0\)\
\-\ minutes\\:\\ 0\\.11852416424318606\ \(0\)\
\-\ older\\:\\ 0\\.11626323874267525\ \(0\)\
\-\ rarely\\:\\ 0\\.11174790374638811\ \(0\)\
\-\ radiotracer\\:\\ 0\\.10935639060880478\ \(0\)\
\-\ injection\\:\\ 0\\.10901052791603906\ \(0\)\
\-\ those\\:\\ 0\\.10719991430774219\ \(0\)\
\-\ sclerotic\\:\\ 0\\.10509236979018435\ \(0\)\
\-\ off\\:\\ 0\\.10466591314607346\ \(0\)\
\-\ nodular\\:\\ 0\\.09976527305473065\ \(0\)\
\-\ thin\\:\\ 0\\.09751904265486519\ \(0\)\
\-\ uptake\\:\\ 0\\.09633162768981644\ \(0\)\
\-\ diagnostic\\:\\ 0\\.09548138626723411\ \(0\)\
\-\ similar\\:\\ 0\\.09548138626723411\ \(0\)\
\-\ to\\:\\ 0\\.09395795121583292\ \(0\)\
\-\ used\\:\\ 0\\.09378774938514557\ \(0\)\
\-\ throughout\\:\\ 0\\.09213570561442597\ \(0\)\
\-\ metastasis\\:\\ 0\\.09181970265038658\ \(0\)\
\-\ very\\:\\ 0\\.08986959125929087\ \(0\)\
\-\ pain\\:\\ 0\\.08965833838647948\ \(0\)\
\-\ does\\:\\ 0\\.08660754205794377\ \(0\)\
\-\ given\\:\\ 0\\.08617870614649993\ \(0\)\
\-\ although\\:\\ 0\\.08528703453999312\ \(0\)\
\-\ areas\\:\\ 0\\.0850552452950648\ \(0\)\
\-\ cancer\\:\\ 0\\.0834441743142247\ \(0\)\
\-\ radiation\\:\\ 0\\.08301977797567325\ \(0\)\
\-\ approximately\\:\\ 0\\.0799366484841225\ \(0\)\
\-\ diffuse\\:\\ 0\\.07856497085425208\ \(0\)\
\-\ secondary\\:\\ 0\\.07425557955149231\ \(0\)\
\-\ 10\\:\\ 0\\.07325635939490513\ \(0\)\
\-\ metastatic\\:\\ 0\\.06870885462036805\ \(0\)\
\-\ increased\\:\\ 0\\.06774452193571263\ \(0\)\
\-\ man\\:\\ 0\\.06632386240895723\ \(0\)\
\-\ can\\:\\ 0\\.06574205813104161\ \(0\)\
\-\ were\\:\\ 0\\.0645773192930411\ \(0\)\
\-\ it\\:\\ 0\\.06412818652188196\ \(0\)\
\-\ case\\:\\ 0\\.06293843183200333\ \(0\)\
\-\ findings\\:\\ 0\\.061829842608061604\ \(0\)\
\-\ multiple\\:\\ 0\\.061276319916405676\ \(0\)\
\-\ after\\:\\ 0\\.06077453402469496\ \(0\)\
\-\ seen\\:\\ 0\\.05897998698209209\ \(0\)\
\-\ images\\:\\ 0\\.057949532437300305\ \(0\)\
\-\ that\\:\\ 0\\.0543660635094766\ \(0\)\
\-\ disease\\:\\ 0\\.052587359907455014\ \(0\)\
\-\ be\\:\\ 0\\.05082037873783117\ \(0\)\
\-\ as\\:\\ 0\\.05032872025192506\ \(0\)\
\-\ of\\:\\ 0\\.04903279906131224\ \(0\)\
\-\ are\\:\\ 0\\.047537399249901434\ \(0\)\
\-\ this\\:\\ 0\\.04304786367830437\ \(0\)\
\-\ on\\:\\ 0\\.037836182659327706\ \(0\)\
\-\ is\\:\\ 0\\.03430830062252215\ \(0\)\
\-\ in\\:\\ 0\\.031165163458180732\ \(0\)\
